Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon
Thumbnail

STEMI patients are getting younger, more obese and more likely to have a chronic disease

A retrospective analysis found that patients who presented at the Cleveland Clinic with STEMI in recent years were younger and more obese and were more likely to smoke or have hypertension, diabetes and chronic obstructive pulmonary disease (COPD) than those with STEMI in the 1990s.

FDA proposes ban for most powdered gloves

After reviewing available information, the FDA announced a proposal on March 21 to ban most powdered gloves, including powdered surgeon’s gloves, powdered patient examination gloves and absorbable powder for lubricating surgeon’s gloves. The ban would not apply to powdered radiographic protection gloves or non-powdered surgeon gloves and non-powdered patient examination gloves.

Thumbnail

[ARTICLE] Building a Protected PCI Program: Defining Algorithms, Selecting Patients

Offered in cooperation with Abiomed

Good outcomes in revascularizing high-risk, complex PCI patients start with careful patient selection. The secret to success in complete revascularization with Protected PCI involves some art, some science and begins with following proven protocols.

Report: Senate begins inquiry into concurrent surgeries

Senator Orrin G. Hatch of Utah, the head of the Senate Finance Committee, has asked 20 hospital systems for information on concurrent surgeries from 2011 to 2015, the Boston Globe reports.

FDA advisory panel votes in favor of Abbott’s Absorb bioresorbable drug-eluting stent

An FDA advisory panel voted on March 15 to affirm that the benefits of the Absorb fully bioresorbable drug-eluting stent (Abbott Vascular) outweighed its risks and that the device was safe and effective as a treatment for coronary artery disease.

Teleflex recalls intra-aortic balloon catheter kits and percutaneous insertion kits

Teleflex announced on March 11 that it had voluntarily recalled the Arrow International intra-aortic balloon catheter kits and percutaneous insertion kits.

Thumbnail

Researchers develop model of in-hospital mortality for patients undergoing TAVR

Researchers have developed a model of in-hospital mortality for patients undergoing transcatheter aortic valve replacement (TAVR) using data from the Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter Valve Therapy (TVT) registry. The model will be incorporated in the registry’s software and will help select patients who may benefit from TAVR.

FDA approves catheter to treat patients in type 1 atrial flutter

The FDA approved the Blazer open-irrigated (OI) radiofrequency ablation catheter (Boston Scientific) on March 10 to treat patients with type 1 atrial flutter.

Displaying 1425 - 1432 of 2710

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.